Narrative review of clinical prediction models for paediatric community acquired pneumonia

Chris A Rees1, Stuart Haggie2, Todd A Florin3

  • 1Division of Pediatric Emergency Medicine, Emory University School of Medicine, Atlanta, GA, United States of America; Department of Emergency Medicine, Children's Healthcare of Atlanta, Atlanta, GA, United States of America.

PubMed

Insights

Clinical prediction models for pediatric community-acquired pneumonia (CAP) are crucial for identifying at-risk children. While models exist for LMICs and HICs, further validation and implementation are needed, especially in LMICs.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Epidemiology

Background:

  • Community-acquired pneumonia (CAP) significantly impacts global child health, with varying morbidity and mortality rates between low- and middle-income countries (LMICs) and high-income countries (HICs).
  • The disparity in CAP outcomes necessitates the development of setting-specific clinical prediction models to identify children at high risk.

Purpose of the Study:

  • To review and outline published clinical prediction models for pediatric CAP-related outcomes in both LMICs and HICs.
  • To assess the current landscape of predictive modeling for pediatric CAP and identify gaps in research and implementation.

Main Methods:

  • Systematic review of published clinical prediction models for pediatric CAP.
  • Categorization of models based on predicted outcomes (treatment failure, poor outcomes, mortality, disease severity, need for major medical interventions) and geographical setting (LMICs vs. HICs).

Main Results:

  • In LMICs, four models predict treatment failure, two predict poor outcomes, and eight predict mortality for pediatric CAP. No LMIC models have documented clinical implementation impact.
  • In HICs, three models assess disease severity and one predicts the need for major medical interventions for pediatric CAP.

Conclusions:

  • Existing clinical prediction models offer a foundation for risk stratification in high-income countries, but require broader external validation and implementation.
  • There is a critical need for the development, validation, and implementation of effective clinical prediction models for pediatric CAP, particularly in LMICs, to improve patient outcomes.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
146
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
201
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.8K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
287